The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Inhibition of Histone Deacetylation Blocks Cardiac Hypertrophy Induced by Angiotensin II Infusion and Aortic Banding
Open accessAbstract
Background— A number of distinct stress signaling pathways in myocardium cause cardiac hypertrophy and heart failure. Class II histone deacetylases (HDACs) antagonize several stress-induced pathways and hypertrophy. However, cardiac hypertrophy induced by transgenic overexpression of the homeodomain only protein, HOP, can be prevented by the nonspecific HDAC inhibitors trichostatin A and valproic acid, suggesting that alternate targets that oppose class II HDAC function might exist in myocardium. We tested the effects of several HDAC inhibitors, including a class I HDAC-selective inhibitor, SK-7041, on cardiac hypertrophy induced by angiotensin II (Ang II) treatment or aortic banding (AB). Methods and Results— Cardiac hypertrophy was induced by chronic infusion of Ang II or by AB in mice or rats and evaluated by determining the ratio of heart weight to body weight or to tibia length, cross-sectional area, or echocardiogram. Cardiac hypertrophy induced by Ang II or AB for 2 weeks was significantly reduced by simultaneous administration of trichostatin A, valproic acid, or SK-7041. Echocardiogram revealed that exaggerated left ventricular systolic dimensions were relieved by HDAC inhibitors. HDAC inhibitors partially reversed preestablished cardiac hypertrophy and improved survival of AB mice. The expressions of atrial natriuretic factor, α-tubulin, β-myosin heavy chain, and interstitial fibrosis were reduced by HDAC inhibition. Conclusions— These results suggest that the predominant effect of HDAC inhibition, mainly mediated by class I HDACs, is to prevent cardiac hypertrophy in response to a broad range of agonist and stretch stimuli.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887
Yoshida, M., Kijima, M., Akita, M., & Beppu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44885-x · Cited by 1,854
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy
Zhang, C. L., McKinsey, T. A., Chang, S., Antos, C. L., Hill, J. A., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00861-9 · Cited by 973
THE CELLULAR AND MOLECULAR RESPONSE OF CARDIAC MYOCYTES TO MECHANICAL STRESS
Sadoshima, J., & Izumo, S. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.551 · Cited by 864
Post-translational modifications regulate microtubule function
Westermann, S., & Weber, K. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1260 · Cited by 717
Gui, C.-Y., Ngo, L., Xu, W. S., Richon, V. M., & Marks, P. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307708100 · Cited by 550
Histone deacetylase inhibitors as new cancer drugs
Marks, P. A., Richon, V. M., Breslow, R., & Rifkind, R. A. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00010 · Cited by 531
Izumo, S., Lompré, A. M., Matsuoka, R., Koren, G., Schwartz, K., Nadal-Ginard, B., & Mahdavi, V (1987) · Journal of Clinical Investigation · doi:10.1172/jci112908 · Cited by 447
Signaling Network Model of Chromatin
Schreiber, S. L., & Bernstein, B. E. (2002) · Cell · doi:10.1016/s0092-8674(02)01196-0 · Cited by 393
Sizing up the heart: development redux in disease
Olson, E. N., & Schneider, M. D. (2003) · Genes & Development · doi:10.1101/gad.1110103 · Cited by 385
Kook, H., Lepore, J. J., Gitler, A. D., Lu, M. M., Wing-Man Yung, W., Mackay, J., Zhou, R., Ferrari, V., Gruber, P., & Epstein, J. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19137 · Cited by 332
Self-citationAlcendor, R. R., Kirshenbaum, L. A., Imai, S.-I., Vatner, S. F., & Sadoshima, J. (2004) · Circulation Research · doi:10.1161/01.res.0000147557.75257.ff · Cited by 303
Hop Is an Unusual Homeobox Gene that Modulates Cardiac Development
Chen, F., Kook, H., Milewski, R., Gitler, A. D., Lu, M. M., Li, J., Nazarian, R., Schnepp, R., Jen, K., Biben, C., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00932-7 · Cited by 288
Self-citationToward transcriptional therapies for the failing heart: chemical screens to modulate genes
McKinsey, T. A., & Olson, E. N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524144 · Cited by 288
Dose-dependent Blockade to Cardiomyocyte Hypertrophy by Histone Deacetylase Inhibitors
Antos, C. L., McKinsey, T. A., Dreitz, M., Hollingsworth, L. M., Zhang, C.-L., Schreiber, K., Rindt, H., Gorczynski, R. J., & Olson, E. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303113200 · Cited by 269
Signaling chromatin to make muscle
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00389-7 · Cited by 198
Gusterson, R. J., Jazrawi, E., Adcock, I. M., & Latchman, D. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211762200 · Cited by 188
Mixed signals in heart failure: cancer rules
Hoshijima, M., & Chien, K. R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15380 · Cited by 162
Park, J., Jung, Y., Kim, T. Y., Kim, S. G., Jong, H.-S., Lee, S. E., Kim, D.-K., Lee, J., Kim, N. K., Kim, T., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0709 · Cited by 143
Self-citationKawamura, T., Ono, K., Morimoto, T., Wada, H., Hirai, M., Hidaka, K., Morisaki, T., Heike, T., Nakahata, T., Kita, T., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412428200 · Cited by 130
Histone Deacetylase in Carcinogenesis and Its Inhibitors as Anti-cancer Agents
Kim, D. H., Kim, M., & Kwon, H.-J. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.110 · Cited by 123
A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy
Shah, B. H., & Catt, K. J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00079-8 · Cited by 119
Mixed signals in heart failure: cancer rules
Hoshijima, M., & Chien, K. R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215380 · Cited by 118
Nervi, C., Borello, U., Fazi, F., Buffa, V., Pelicci, P. G., & Cossu, G. (2001) · PubMed · Cited by 90
Contard, F., Koteliansky, V., Marotte, F., Dubus, I., Rappaport, L., & Samuel, J. (1991) · PubMed · Cited by 87
Homeobox Protein Hop Functions in the Adult Cardiac Conduction System
Ismat, F. A., Zhang, M., Kook, H., Huang, B., Zhou, R., Ferrari, V. A., Epstein, J. A., & Patel, V. V. (2005) · Circulation Research · doi:10.1161/01.res.0000163108.47258.f3 · Cited by 86
Self-citationEssential roles for G1cyclin-dependent kinase activity in development of cardiomyocyte hypertrophy
Tamamori, M., Ito, H., Hiroe, M., Terada, Y., Marumo, F., & Ikeda, M. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.6.h2036 · Cited by 69
Post-translational modifications of cardiac tubulin during chronic heart failure in the rat
Belmadani, S., Poüs, C., Ventura‐Clapier, R., Fischmeister, R., & Méry, P. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1016554104209 · Cited by 48
Kim, D.-K., Lee, J. Y., Kim, J.-S., Ryu, J.-H., Choi, J.-Y., Lee, J., Im, G.-J., Kim, T.-K., Seo, J. W., Park, H., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030377q · Cited by 45
Self-citationRyu, J. K., Lee, W. J., Lee, K. H., Hwang, J., Kim, Y., Yoon, Y. B., & Kim, C. Y. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.05.040 · Cited by 45
Davis, F. J., Pillai, J. B., Gupta, M., & Gupta, M. P. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00789.2004 · Cited by 44
Cited by
Regulation of cardiac hypertrophy by intracellular signalling pathways
Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,866
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage
Bartolomaeus, H., Balogh, A., Yakoub, M., Homann, S., Markó, L., Höges, S., Tsvetkov, D., Krannich, A., Wundersitz, S., Avery, E. G., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036652 · Cited by 815
Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility
Montgomery, R. L., Davis, C. A., Potthoff, M. J., Haberland, M., Fielitz, J., Qi, X., Hill, J. A., Richardson, J. A., & Olson, E. N. (2007) · Genes & Development · doi:10.1101/gad.1563807 · Cited by 712
Tham, Y. K., Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., & McMullen, J. R. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1477-x · Cited by 708
Metadata
- Authors
- Kee, H. J., Sohn, I. S., Nam, K. I., Park, J. E., Qian, Y. R., Yin, Z., Ahn, Y., Jeong, M. H., Bang, Y.-J., Kim, N., Kim, J.-K., Kim, K. K., Epstein, J. A., & Kook, H.
- Venue
- Circulation
- Published
- 2006-01-03
- Volume
- 113
- Issue
- 1
- Pages
- 51-59
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2142491779
- Cited by
- 368
- References
- 32
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.